Ocugen to co-develop Covaxin with Bharat Biotech

In a major booster for ‘Make in India’, vaccine maker Bharat Biotech has inked a binding letter of intent (LoI) with US-based biopharmaceutical player Ocugen Inc for co-developing India’s first indigenous Covid-19 vaccine candidate Covaxin for the US market.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/2WEemtJ